EverSource Wealth Advisors’s LeMaitre Vascular LMAT Stock Holding History

EverSource Wealth Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$142K	Buy	1,485 +92	+7%	+$9.43K	﹤0.01%	1197
2026 Q1	$152K	Buy	1,393 +308	+28%	+$29.4K	﹤0.01%	1200
2025 Q4	$88K	Buy	1,085 +91	+9%	+$7.83K	﹤0.01%	1386
2025 Q3	$87K	Buy	994 +427	+75%	+$38.1K	﹤0.01%	1363
2025 Q2	$47.1K	Buy	+567	New	+$47.4K	﹤0.01%	1655
2025 Q1	–	Sell	-13	Closed	-$1.2K	–	4109
2024 Q4	$1.2K	Buy	+13	New	+$1.25K	﹤0.01%	2900

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EverSource Wealth Advisors's LMAT Position: Q2 2026 in Review

EverSource Wealth Advisors increased its LeMaitre Vascular (LMAT) stake by 6.6% in Q2 2026, buying an estimated $9.43K and bringing the position to 1,485 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #1197.

EverSource Wealth Advisors first reported a position in LMAT in Q4 2024 and has held it in 6 quarters since. The position peaked at $152K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

EverSource Wealth Advisors held 1,485 shares of LeMaitre Vascular worth $142K as of Q2 2026.
EverSource Wealth Advisors bought 92 LeMaitre Vascular shares in Q2 2026, an estimated $9.43K.
LeMaitre Vascular made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1197 holding.
EverSource Wealth Advisors first reported a position in LeMaitre Vascular in Q4 2024 and has held it in 6 quarters since.
EverSource Wealth Advisors's LeMaitre Vascular position peaked at $152K in Q1 2026.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.